We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
CCMD
1151
Cypress Capital Management (Delaware)
Delaware
$1.42M
FA
1152
FDx Advisors
Illinois
$1.42M -$1.32M -2,816 -48%
ACM
1153
Argent Capital Management
Missouri
$1.42M -$89.1K -190 -6%
GKWIM
1154
Gerber Kawasaki Wealth & Investment Management
California
$1.41M +$200K +427 +16%
ARMC
1155
American Research & Management Company
Massachusetts
$1.4M +$22.5K +48 +2%
HCP
1156
Holt Capital Partners
Texas
$1.4M
MLM
1157
Mount Lucas Management
Pennsylvania
$1.4M +$1.41M +2,999 New
ACM
1158
Ascendant Capital Management
California
$1.4M +$1.41M +3,000 New
CDH
1159
Charles D. Hyman
$1.38M +$149K +317 +12%
JCM
1160
Jacobi Capital Management
Pennsylvania
$1.38M +$8.44K +18 +0.6%
BRM
1161
Boston Research & Management
Massachusetts
$1.38M +$198K +423 +17%
FNBOH
1162
First National Bank of Hutchinson
Kansas
$1.37M -$45K -96 -3%
CRWM
1163
Castle Rock Wealth Management
California
$1.37M +$140K +298 +13%
Qube Research & Technologies (QRT)
1164
Qube Research & Technologies (QRT)
United Kingdom
$1.36M -$6.64M -14,154 -83%
PNAA
1165
Pictet North America Advisors
Switzerland
$1.36M -$377K -803 -22%
SXL
1166
Summit X LLC
Missouri
$1.36M -$65.6K -140 -5%
SOAMC
1167
Spirit of America Management Corp
New York
$1.35M
BFS
1168
Bard Financial Services
Connecticut
$1.35M +$1.36M +2,900 New
DA
1169
Dash Acquisitions
California
$1.34M +$1.35M +2,883 New
SFA
1170
Sequoia Financial Advisors
Ohio
$1.33M +$23.9K +51 +2%
PRC
1171
Pearl River Capital
Michigan
$1.33M +$1.09M +2,317 +421%
KA
1172
Kovack Advisors
Florida
$1.33M +$54.4K +116 +4%
MAFM
1173
Mid Atlantic Financial Management
Pennsylvania
$1.33M +$95.2K +203 +8%
ZB
1174
Zions Bancorporation
Utah
$1.32M -$419K -894 -24%
TAM
1175
Tealwood Asset Management
Minnesota
$1.32M -$84.4K -180 -6%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.